FDFT1 and cancer: Among them, farnesyl-diphosphate farnesyltransferase 1 (FDFT1, EC 2.5.1.21, squalene synthase) has been regarded as a likely target in cancer due to its high expression as a biomarker used for diagnosis of various cancers, although in some cancers FDFT1 exhibits lower expression [6,7].